2025 U.S. Pharma Industry and Market Access Key Facts
In 2023, U.S. retail prescription drug market value grew 11.4% to $449.7B, about 9% of total health care outlays1. “Retail
AIFA 2025 Annual Report: Key Insights into Italian Market Access, Pricing, and Pharma and Biotech Innovation
The Italian Medicines Agency has published their annual AIFA Activity Report in 2025, outlining the key facts and figures regarding
Tariffs: Should Pharma and Biotech Manufacturers Relocate / Build Manufacturing in the U.S.?
As U.S. trade policy tightens, pharmaceutical and biotech companies face a pivotal strategic question: does it now make financial sense
2025 German Pharma Industry and Market Access Key Facts and Figures
Germany: Europe’s Largest Pharma Market Germany is one of the key focus markets for pharma, biotech and medtech Market Access
Reshaping U.S. and Global Drug Pricing: What Pharma Needs to Know about MFN and tariffs in 2025
In an effort to combat the high prices for prescription drugs in the U.S., the Trump administration introduced a Most
Are Early Access Programmes the Better Funding Pathway for Biotechs?
Many biotech executives we currently meet report difficulties in securing their next financing round to fund further clinical development and